Nivedita Rana
Overview
Explore the profile of Nivedita Rana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rana N, Kumari S, Sankar M
Chem Asian J
. 2024 Dec;
20(4):e202400719.
PMID: 39715078
The extent of conformational change of the porphyrin macrocycle during the course of protonation was observed, both experimentally and theoretically. For synthesised β-substituted octaphenylporphyrin (OPP) ring systems, these macrocyclic distortions...
2.
Sehgal I, Arora K, Agarwal R, Kumar R, Rana N, Dhooria S, et al.
J Infect Dis
. 2024 Aug;
231(2):532-539.
PMID: 39159179
Background: The role of 2-deoxy-2-18(F) fluoro-D-glucose (FDG) positron emission tomography (PET)-computed tomography (CT) in assessing treatment response in chronic pulmonary aspergillosis (CPA) remains to be determined. The study objective was...
3.
Pandey S, Kaur G, Rana N, Chopra S, Rather I, Kumar R, et al.
Cancer Biother Radiopharm
. 2024 Jul;
39(9):632-643.
PMID: 38977419
The expression of alpha-five beta-three (αVβ3) integrins is upregulated in various malignancies undergoing angiogenesis. The development of integrin antagonists as diagnostic probes makes the αVβ3 integrin a suitable candidate for...
4.
Rohal R, Banerjee D, Rana N, Soma V, Sankar M
Dalton Trans
. 2024 Mar;
53(14):6436-6444.
PMID: 38506309
β-Heptasubstituted porphyrins [MTPP(NO)X; M = 2H, Ni, Cu, and Zn; X = Br, Ph, and PE] were synthesized and their third-order nonlinear optical (NLO) properties explored using the single-beam -scan...
5.
Rana N, Srivastava A, Kumar M, Parmar M, Kumar R, Mittal B
Indian J Nucl Med
. 2024 Feb;
38(4):362-365.
PMID: 38390544
Purpose: The present study aimed to evaluate radiation exposure to staff performing coronary flow reserve (CFR) measurement using N-ammonia. Materials And Methods: The radiation exposure rate during the administration of...
6.
Chopra S, Mathur Y, Roesch F, Moon E, Rana N, Irrinki S, et al.
Acad Radiol
. 2024 Jan;
31(6):2521-2535.
PMID: 38233261
Rationale And Objectives: Fibroblast Activation Protein (FAP) expressing cancer-associated fibroblasts has been a major breakthrough causing a paradigm shift in targeted theranostics focusing on the tumor microenvironment. In this study,...
7.
Chopra S, Walia R, Mathur Y, Roesch F, Moon E, Rana N, et al.
Clin Nucl Med
. 2023 Feb;
48(4):e173-e175.
PMID: 36727882
Metastatic or recurrent adrenocortical carcinoma (ACC) is a potentially fatal malignancy, which poses major challenges in disease management owing to lack of effective systemic therapies. The drastically reduced survival rates...
8.
Pandey S, Walia R, Kumar R, Chopra S, Rana N, Chatterjee D, et al.
Clin Nucl Med
. 2023 Jan;
48(2):e95-e98.
PMID: 36607383
Adrenocortical carcinoma (ACC) is a rare malignancy with a prevalence of 1 to 2 cases/million/year. The diagnosis depends upon endocrine workup followed by imaging with CT, MRI, and 18F-FDG PET/CT....
9.
Kaur G, Shukla J, Sood A, Prakash G, Krishnaraju V, Rana N, et al.
Clin Nucl Med
. 2022 Dec;
48(1):e19-e21.
PMID: 36469075
Duramycin, a 19 amino acids peptide, is known for its potential to target phosphatidylethanolamine. During cell death (apoptosis), rearrangement of membrane phospholipids results in the externalization of phosphatidylethanolamine to the...
10.
Kaur N, Kumar R, Rana N, Krishnaraju V, Mittal B
Indian J Nucl Med
. 2022 Aug;
37(2):147-153.
PMID: 35982818
Objective: radioactivity measurement of positron emission tomography/computed tomography (PET/CT)-guided biopsy tissue specimen to check the viable tumor sampling and predict the nature of the biopsied lesion. Materials And Methods: We...